Time of treatment evaluation (months)
Virologic Success (VL<50copies/ml)
Immunologic Success

(CD4 counts > 200 cells/mm3)

6 months

157/174 (90.2%)

73/162 (45.1%)

12 months

187/202 (92.6%)

114/191 (59.7%)

24 months

193/205 (94.1%)

145/176 (82.4%)

36 months

201/212 (94.8%)

169/184 (91.8%)

48 months

170/201 (84.6%)

162/176 (92.0%)
Table 2: Treatment success and immunologic success during the study (n=244).
Goto home»